128 related articles for article (PubMed ID: 32701043)
1. Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns.
Reynolds G; Slavin M; Teh BW
Leuk Lymphoma; 2020 Oct; 61(10):2292-2294. PubMed ID: 32701043
[No Abstract] [Full Text] [Related]
2. High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
Teh BW; Chui W; Handunnetti S; Tam C; Worth LJ; Thursky KA; Slavin MA
Leuk Lymphoma; 2019 Jun; 60(6):1572-1575. PubMed ID: 30632838
[No Abstract] [Full Text] [Related]
3. Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.
Varughese T; Taur Y; Cohen N; Palomba ML; Seo SK; Hohl TM; Redelman-Sidi G
Clin Infect Dis; 2018 Aug; 67(5):687-692. PubMed ID: 29509845
[TBL] [Abstract][Full Text] [Related]
4. Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report.
Grossi O; Pineau S; Sadot-Lebouvier S; Hay B; Delaunay J; Miailhe AF; Bretonnière C; Jeddi F; Lavergne RA; Le Pape P
Clin Microbiol Infect; 2019 Feb; 25(2):261-263. PubMed ID: 30691617
[No Abstract] [Full Text] [Related]
5. Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Ruchlemer R; Ben-Ami R; Bar-Meir M; Brown JR; Malphettes M; Mous R; Tonino SH; Soussain C; Barzic N; Messina JA; Jain P; Cohen R; Hill B; Mulligan SP; Nijland M; Herishanu Y; Benjamini O; Tadmor T; Okamoto K; Arthurs B; Gottesman B; Kater AP; Talha M; Eichhorst B; Korem M; Bogot N; De Boer F; Rowe JM; Lachish T
Mycoses; 2019 Dec; 62(12):1140-1147. PubMed ID: 31520441
[TBL] [Abstract][Full Text] [Related]
6. Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib.
Frei M; Aitken SL; Jain N; Thompson P; Wierda W; Kontoyiannis DP; DiPippo AJ
Leuk Lymphoma; 2020 Oct; 61(10):2488-2491. PubMed ID: 32530347
[No Abstract] [Full Text] [Related]
7. The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy.
Mascarella MA; Schweitzer L; Alreefi M; Silver J; Caglar D; Loo VG; Richardson K; Dufresne P; Lee TC; Sadeghi N
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):49. PubMed ID: 31619294
[TBL] [Abstract][Full Text] [Related]
8. Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.
Peri AM; Rossio R; Tafuri F; Benzecry V; Grancini A; Reda G; Bandera A; Peyvandi F
Ann Hematol; 2019 Dec; 98(12):2847-2849. PubMed ID: 31741032
[No Abstract] [Full Text] [Related]
9. Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia.
Stankowicz M; Banaszynski M; Crawford R
J Oncol Pharm Pract; 2019 Apr; 25(3):710-714. PubMed ID: 29343153
[TBL] [Abstract][Full Text] [Related]
10. Cerebral aspergillosis in a patient on ibrutinib therapy-A predisposition not to overlook.
Faisal MS; Shaikh H; Khattab A; Albrethsen M; Fazal S
J Oncol Pharm Pract; 2019 Sep; 25(6):1486-1490. PubMed ID: 30045683
[TBL] [Abstract][Full Text] [Related]
11. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.
Cummins KC; Cheng MP; Kubiak DW; Davids MS; Marty FM; Issa NC
Leuk Lymphoma; 2019 Feb; 60(2):527-530. PubMed ID: 30037292
[No Abstract] [Full Text] [Related]
12. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W
Lancet Haematol; 2019 Feb; 6(2):e67-e78. PubMed ID: 30642819
[TBL] [Abstract][Full Text] [Related]
13. [Chronic Lymphocytic Leukemia. New targeted therapy option Ibrutinib].
Bruhn C
Med Monatsschr Pharm; 2014 Jul; 37(7):268-9. PubMed ID: 25065170
[No Abstract] [Full Text] [Related]
14. Management of hypogammaglobulinemia and recurrent infections in a chronic lymphocytic leukemia patient receiving ibrutinib.
Jiang F; Verma P
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):324-325. PubMed ID: 29174859
[No Abstract] [Full Text] [Related]
15. Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib.
Holowka T; Cheung H; Malinis M; Gan G; Deng Y; Perreault S; Isufi I; Azar MM
J Infect Chemother; 2021 Dec; 27(12):1700-1705. PubMed ID: 34389223
[TBL] [Abstract][Full Text] [Related]
16. Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report.
Peri AM; Bisi L; Cappelletti A; Colella E; Verga L; Borella C; Foresti S; Migliorino GM; Gori A; Bandera A
Clin Microbiol Infect; 2018 Jul; 24(7):785-786. PubMed ID: 29427802
[No Abstract] [Full Text] [Related]
17. Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia.
Rider TG; Grace RJ; Newman JA
Br J Haematol; 2016 Apr; 173(2):326-7. PubMed ID: 26195269
[No Abstract] [Full Text] [Related]
18. Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia.
Rogers KA; Ruppert AS; Bingman A; Andritsos LA; Awan FT; Blum KA; Flynn JM; Jaglowski SM; Lozanski G; Maddocks KJ; Byrd JC; Woyach JA; Jones JA
Leukemia; 2016 Feb; 30(2):346-50. PubMed ID: 26442611
[TBL] [Abstract][Full Text] [Related]
19. The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.
Wiestner A
Haematologica; 2015 Dec; 100(12):1495-507. PubMed ID: 26628631
[TBL] [Abstract][Full Text] [Related]
20. A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib.
Lee CS; Rattu MA; Kim SS
J Oncol Pharm Pract; 2016 Feb; 22(1):92-104. PubMed ID: 25425007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
